Literature DB >> 6225134

Photodynamic inactivation of R3230AC mammary carcinoma in vitro with hematoporphyrin derivative: effects of dose, time, and serum on uptake and phototoxicity.

R Hilf, P B Leakey, S J Sollott, S L Gibson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6225134     DOI： 10.1111/j.1751-1097.1983.tb04532.x

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN： 0031-8655            Impact factor:   3.421


× No keyword cloud information.
  6 in total

1.  Effect of photofrin II and light energy on retinoblastoma-like cells in vitro. Dose-response relationships, effect of light dose rate and recovery ratio.

Authors:  J Winther
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

2.  Biological and biophysical properties of the tumor-localizing component of hematoporphyrin derivative.

Authors:  D Kessel; M L Cheng
Journal:  Cancer Res       Date:  1985-07       Impact factor: 12.701

3.  Photodynamic therapy of bladder cancer--uptake and phototoxicity of photosan in vitro.

Authors:  K Miller; E Reich; A Rück; R Hautmann
Journal:  Urol Res       Date:  1991

4.  Cellular effects of hematoporphyrin derivative photodynamic therapy on normal and neoplastic rat bladder cells.

Authors:  J R Shulok; J E Klaunig; S H Selman; P J Schafer; P J Goldblatt
Journal:  Am J Pathol       Date:  1986-02       Impact factor: 4.307

5.  Morphologic studies of bladder tumors treated with hematoporphyrin derivative photochemotherapy.

Authors:  J E Klaunig; S H Selman; J R Shulok; P J Schafer; S L Britton; P J Goldblatt
Journal:  Am J Pathol       Date:  1985-05       Impact factor: 4.307

6.  In vitro photosensitization of tumour cell enzymes by photofrin II administered in vivo.

Authors:  S L Gibson; R S Murant; M D Chazen; M E Kelly; R Hilf
Journal:  Br J Cancer       Date:  1989-01       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.